David Goldfarb, MD
NYU Langone Health
7
7
6
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Lama Nazzal, MD
NYU Langone Health
Shared therapeutic areas:
Worked with same sponsors:
Mohamed mamdouh Elsayed, MD
Lecturer
Shared therapeutic areas:
Yoseph Caraco, MD
Hadassah Medical Organization
Shared therapeutic areas:
Giuseppe Remuzzi, MD
Istituto Di Ricerche Farmacologiche Mario Negri
Shared therapeutic areas:
John F Tisdale, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Wanpen Vongpatanasin, MD
University of Texas Southwestern Medical Center
Shared therapeutic areas:
Mohammad Ali Tabibi, Dr
Pardis Specialized Wellness Institute
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Tomasz Masior
VectivBio AG
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Gut Kidney Axis in Enteric Hyperoxaluria
Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease
Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With Cystinuria
Effect of Hydroxycitrate on Urine Chemistry
Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
Health-related Quality of Life in Rare Kidney Stone
All 7 trials loaded